C.H. Robinson’s Q3 2026 Earnings: What to Expect
📅 C.H. Robinson is scheduled to announce fiscal Q3 2026 earnings before the market opens on Wednesday, Oct. 28.
💰 Analysts expect a quarterly profit of $1.72 per share, marking a 22.9% increase from the previous year's quarter.
📈 The company has topped Wall Street's bottom-line estimates in each of the last four consecutive quarters.
🚀 For the current fiscal year ending in December, analysts project a profit of $6.26 per share, up 23% from fiscal 2025.
🔮 Earnings per share are forecasted to grow 17.9% year over year to reach $7.38 in fiscal 2027.
📉 CHRW shares have soared 12.6% over the past 52 weeks, exceeding the State Street Industrial Select Sector SPDR ETF's return.
💸 The proposed $5.8 billion acquisition of RXO has introduced uncertainty and caused a 9% drop in premarket trading.
🤝 Management expects the RXO deal to deliver $300 million in annual synergies within two years.
⚠️ Investor concerns regarding integration risks and the financial burden of the transaction have tempered sentiment.
🏆 Wall Street analysts maintain a 'Strong Buy' rating overall with 17 out of 24 recommending 'Strong Buy'.
🎯 The mean price target for CHRW is $192.96, indicating a 36.7% potential upside from current levels.
- Analysts expect a quarterly profit of $1.72 per share for Q3 2026, representing a significant 22.9% increase from the year-ago quarter.
- The company has topped Wall Street's bottom-line estimates in each of the last four consecutive quarters.
- For the current fiscal year ending in December, analysts project a profit of $6.26 per share, up 23% from fiscal 2025.
- Earnings per share are forecasted to grow 17.9% year over year to reach $7.38 in fiscal 2027.
- CHRW shares have soared 12.6% over the past 52 weeks, exceeding the State Street Industrial Select Sector SPDR ETF's return.
- Management expects the proposed RXO acquisition to deliver $300 million in annual synergies within two years and boost earnings per share within nine months of closing.
- Wall Street analysts maintain a 'Strong Buy' rating overall, with 17 out of 24 recommending 'Strong Buy'.
- The proposed $5.8 billion acquisition of RXO has introduced uncertainty and caused shares to drop 9% in premarket trading following the announcement.
- Investor concerns over integration risks and the financial burden of the transaction have tempered sentiment regarding the company's ability to translate efficiency gains into sustained growth.